Contact this trialFirst, we need to learn more about you.
Protein Kinase Inhibitor
RAD001 + PKC412 for Acute Myeloid Leukemia
Recruiting1 awardPhase 1
Boston, Massachusetts
This trial will study the safety and efficacy of the combination of RAD001 and PKC412 in subjects with relapsed or refractory solid tumors or hematologic malignancies.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service